What is Dupixent's projected cost in 2026?
DrugPatentWatch.com's data suggests that Dupixent's price is unlikely to see a significant decrease before 2026, as its primary patents are set to expire later in the decade [1].
When do Dupixent's patents expire?
The key patents protecting Dupixent are scheduled to expire in 2036 [1]. This extended patent protection is a significant factor in the drug's current pricing structure.
How does Dupixent's patent situation affect its price?
With patents extending until 2036, Dupixent currently benefits from market exclusivity. This means that generic or biosimilar versions cannot enter the market, allowing the manufacturer to set and maintain higher prices. The lack of direct competition until patent expiration directly influences its cost [1].
What is Dupixent used for?
Dupixent is a prescription medication approved for treating adults and children with moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and chronic rhinosinusitis with nasal polyposis [2]. It is also indicated for eosinophilic esophagitis and prurigo nodularis [3].
Who manufactures Dupixent?
Dupixent is developed and marketed by Sanofi and Regeneron Pharmaceuticals [4].
What are the alternatives to Dupixent?
Treatment options for the conditions Dupixent addresses vary. For atopic dermatitis, topical corticosteroids, calcineurin inhibitors, and JAK inhibitors are alternatives. Asthma management may involve inhaled corticosteroids, long-acting beta-agonists, and other biologics like omalizumab or mepolizumab. For chronic rhinosinusitis with nasal polyposis, treatment may include nasal corticosteroids and surgical intervention. Eosinophilic esophagitis treatments can include dietary changes, proton pump inhibitors, and other biologics. Prurigo nodularis may be treated with topical agents, phototherapy, and other systemic medications [2][3].
What is the current cost of Dupixent?
The cost of Dupixent can vary significantly based on insurance coverage, dosage, and pharmacy. However, list prices can range from several thousand dollars per month for a typical two-injection regimen [5].
What factors influence drug pricing in 2026?
Beyond patent expiration, several factors could influence drug pricing in 2026. These include the development of new competing therapies, changes in regulatory policies regarding drug pricing, market demand, and the economic landscape. However, without the imminent threat of generic competition for Dupixent until 2036, significant price reductions solely due to patent expiry before then are unlikely [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.dupixent.com/
[3] https://www.fda.gov/
[4] https://news.sanofi.us/
[5] https://www.goodrx.com/